Global Haemophilia Therapeutics Market to Hit $10.4 billion by 2017

Feb. 1, 2011 - PRLog -- The report “Hemophilia: Pipeline Assessment and Market Forecasts to 2017” available at http://www.piribo.com/publications/drug_discovery/hemophilia.html is an essential source of information and analysis on the global haemophilia market. It identifies the key trends shaping and driving the global haemophilia market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global haemophilia sector.

The analysis suggests that the global haemophilia therapeutics market was valued at $6.5 billion in 2009. It is expected to increase at a Compound Annual Growth Rate (CAGR) of 5.8% from $6.5 billion in 2009 to $10.4 billion by 2017. This slow growth of 5.8% is primarily attributed to a low diagnosis rate and the high cost of therapy. The safety and efficacy profiles of the existing therapies are moderate. The major treatments for haemophilia A include recombinant factor VIII drugs such as NovoSeven, Kogenate, Advate, ReFacto, Xyntha, Feiba and others for severe haemophilia cases. For mild to moderate haemophilia cases, DDAVP (desmopressin), which stimulates the release of factor VIII and also increases the level of proteins in the blood, is used. For haemophilia B, the most widely used branded drug is BeneFIX, a clotting factor from Pfizer Inc.

The report “Hemophilia: Pipeline Assessment and Market Forecasts to 2017” is available from Piribo at:
http://www.piribo.com/publications/drug_discovery/hemophi...

Piribo product ID: GDA01208

About Piribo

Piribo http://www.piribo.com/publications/drug_discovery/index.html is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.